Skip to main content
Clinical Trials/KCT0005086
KCT0005086
Not yet recruiting
未知

Cognitive decline according to Amyloid Uptake in patients with post-Stroke cognitivE impairment

The Catholic University of Korea, Eunpyeong St. Mary's Hospital0 sites196 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the nervous system
Sponsor
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Enrollment
196
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) patients who were diagnosed as mild cognitive impairment within 3 months from acute cerebral infarct
  • 2\) aged 60\-80
  • 3\) cognitive impairments were newly developed or aggravated after cerebral infarct

Exclusion Criteria

  • 1\) patient who was diagnosed as dementia before the cerebral infarct
  • 2\) other neurological, psychiatric, or medical disease that cause cognitive impairment
  • 3\) patient taking a cholinesterase inhibitor within 3 months from baseline
  • 4\) strategic infarct or large territory infarct involving cortical areas
  • 5\) modified Rankin Scale (mRS) \>3
  • 6\) patients with aphasia
  • 7\) blindness, deafness, or severe language impairment that might be impossible for study evaluations
  • 8\) severe liver disease or kidney disease that needs dialysis
  • 9\) malignancy that was not completely resolved
  • 10\) schizophremia or bipolar disorders (DSM\-IV Axis I psychiatric disease)

Outcomes

Primary Outcomes

Not specified

Similar Trials